Trifluoroacetic acid → N-(1-((S)-morpholin-2-ylmethyl)-1H-pyrazol-4-yl)-4-(4-(5-(1-phenylethyl)pyrimidin-2-yl)piperazin-1-yl)-1,3,5-triazin-2-amine
Reaction equation
[C:1]1([CH:7]([C:9]2[CH:10]=[N:11][C:12]([N:15]3[CH2:20][CH2:19][N:18]([C:21]4[N:26]=[CH:25][N:24]=[C:23]([NH:27][C:28]5[CH:29]=[N:30][N:31]([CH2:33][C@H:34]6[O:39][CH2:38][CH2:37][N:36](C(OC(C)(C)C)=O)[CH2:35]6)[CH:32]=5)[N:22]=4)[CH2:17][CH2:16]3)=[N:13][CH:14]=2)[CH3:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1.FC(F)(F)C(O)=O>ClCCl>[NH:36]1[CH2:37][CH2:38][O:39][C@H:34]([CH2:33][N:31]2[CH:32]=[C:28]([NH:27][C:23]3[N:22]=[C:21]([N:18]4[CH2:17][CH2:16][N:15]([C:12]5[N:11]=[CH:10][C:9]([CH:7]([C:1]6[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=6)[CH3:8])=[CH:14][N:13]=5)[CH2:20][CH2:19]4)[N:26]=[CH:25][N:24]=3)[CH:29]=[N:30]2)[CH2:35]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (2S)-tert-butyl 2-((4-(4-(4-(5-(1-phenylethyl)pyrimidin-2-yl)piperazin-1-yl)-1,3,5-triazin-2-ylamino)-1H-pyrazol-1-yl)methyl)morpholine-4-carboxylate (130 mg, crude) in dichloromethane (6 mL) was dropwise added trifluoroacetic acid (2 mL). The reaction mixture was stirred at room temperature for 0.5 hour and then concentrated. The residue was purified by Prep-HPLC to provide N-(1-((S)-morpholin-2-ylmethyl)-1H-pyrazol-4-yl)-4-(4-(5-(1-phenylethyl)pyrimidin-2-yl)piperazin-1-yl)-1,3,5-triazin-2-amine as a white solid, which was then separated by Chiral-HPLC to afford N-(1-((S)-morpholin-2-ylmethyl)-1H-pyrazol-4-yl)-4-(4-(5-((R)-1-phenylethyl)pyrimidin-2-yl)piperazin-1-yl)-1,3,5-triazin-2-amine as a white solid (15.4 mg, 17%).
Workup
- concentrationconcentrated
- customThe residue was purified by Prep-HPLC
Sources & evidence
- ORD record
- ord-17e7dabfd6054eb8ba107fca4510a374
- Source dataset
- uspto-grants-2016_05
- Patent number
- US09334263B2
Reaction notes
Loading…